Zidovudine Now or Later?

Research output: Contribution to journalEditorialpeer-review

Abstract

In 1985, zidovudine was found to have in vitro activity against the human immunodeficiency virus (HIV). The first large clinical trial, initiated in February 1986 in patients with advanced HIV disease, was stopped by the safety monitoring board after seven months because there was a significant survival advantage for those who received zidovudine. The drug was approved by the Food and Drug Administration (FDA) in March 19871,2. Its efficacy has now been demonstrated for nearly every clinical and laboratory index that it makes sense to study. These include prolongation of survival, delay of the occurrence of an AIDS-defining…

Original languageEnglish (US)
Pages (from-to)351-352
Number of pages2
JournalNew England Journal of Medicine
Volume329
Issue number5
DOIs
StatePublished - Jul 29 1993

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Zidovudine Now or Later?'. Together they form a unique fingerprint.

Cite this